Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-15-043423
Filing Date
2015-06-04
Accepted
2015-06-04 16:05:45
Documents
4
Effectiveness Date
2015-06-04

Document Format Files

Seq Description Document Type Size
1 S-8 a15-13384_1s8.htm S-8 119786
2 EX-5.1 a15-13384_1ex5d1.htm EX-5.1 9361
3 EX-23.1 a15-13384_1ex23d1.htm EX-23.1 3046
4 EX-23.2 a15-13384_1ex23d2.htm EX-23.2 3444
  Complete submission text file 0001104659-15-043423.txt   136659
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-204720 | Film No.: 15913093
SIC: 2834 Pharmaceutical Preparations